If this hits or drops below 0.095. I think it's heading for around 6c. hopefully Ill be able to top up.
This idea is based on my technical analysis only. Do your research and trade on your own risk!
Bullish divergence on this penny weed stock. I think we will see a major trend reversal within the next few weeks. Catalysts include the upcoming election and also Congress setting to vote on legalization. Now might be a good time to scoop up some shares while they are cheap because this sector will *most likely* be very hot soon.
Some predictions down, once hits bottom line, it will go back up due to break through.
George Sharp CEO + trade analysis would indicate pennies coming folks!
Couple things: 1. First time this stock has attempted a cloud break in a while. 2. All technicals are setup for a breakout off of the All time bottom. 3. PARSAR on 3 and 6 the month charts first time since Jan when it had its last major run. 4. Broke above a key resistance point at .0020 5. RSI still very low on the 3 and 6 month charts
This thing has sketchiness written all over it. Twitter and Facebook and ripe with shills pushing this stock as the next big thing. IMO that is sometimes more clear of an indicator than any chart that a stock is doomed. Yesterday this thing shot up 200%, and its got the potential for gains in the future, but it could also go tumbling back to 0.001 leaving you...
THLD triggered my first level 1.29$ above the pennie mode. Main reason for it might be the release of phase III data from its clinical stage studies of Tarloxotinib. The data will be released somewhere in September. My next levels are 2.15$ and 2.75$.
Did you ever heard about kidney and heart insufficiencies to be the most accompanying disease? I don't refer on diabetes type 2 but the real first sign an human organism is suffering from serious weakness. Here is DiaMedica with KLK1 and DM199 to reconstruct bradykinin preventing reduced blood flow after strokes or chronical diseases which narrow blood...
$SVA made a good perfo in 2015 and for me this is a buy. Next target is 0.319 again and 215 high 0.4$. My extensions are on 0.54 and 0.635$.
Microbix is near on it's alltime lows, the website is offline but last news I found was a growth net income per share $0.001 in Q3. Worth watching it
NCCN® awarded grants for research of bavituximab. Peregrine jumped above the 2012 low is back again for a rally out of its penny range. ;)
macd and stoic crossed/cci and percent r upper range see why this is essential in our book on amazon/obv mf good/relative strength good/adx trending/diversify /stop loss 8 ema daily close below
green candle after doji small cap etf stoch crossed money flow good get our book on amazon diversify with foreign candidates relative strength strong cci and per r rising
macd crossed j hook pattern get our book on amazon best pattern bollinger bands expanding good candle rsi strong strong cci top of percent r and cci money flow strong good long base
probably pull back to cloud then take off get our book on playing fib pullbacks on amazon management owns 25 percent no debt lots of cash projects in safe areas
looks good next stop is 50 day moving average then cloud pick our book on amazon pennies to thousands to see our rules for entry and exit